Biolase's average Accounts Payable for the
three
months ended in Sep. 2024 was $4.25 Mil. Biolase's Cost of Goods Sold for the
three
months ended in Sep. 2024 was $6.47 Mil.
Hence, Biolase's Days Payable for the
three
months ended in Sep. 2024 was 59.90.
The historical rank and industry rank for Biolase's Days Payable or its related term are showing as below:
BIOLQ's Days Payable is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 68.07 * Ranked among companies with meaningful Days Payable only.
Biolase's Days Payable
declined
from Sep. 2023 (85.79) to Sep. 2024 (59.90).
It may suggest that Biolaseaccelerated paying its suppliers.
Biolase Days Payable Related Terms
Biolase Days Payable Historical Data
* Premium members only.
The historical data trend for Biolase's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Biolase's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biolase Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biolase's Days Payable distribution charts can be found below:
* The bar in red indicates where Biolase's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Biolase's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biolase (BIOLQ) has a Days Payable of 59.90 as of Sep. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biolase and its competitors.
Is Biolase's Days Payable too high?
Biolase's current Days Payable is 59.90. The Medical Devices & Instruments industry median Days Payable is 68.07. Biolase's value of 59.90 is 12% below this industry median. Overall, Biolase has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Biolase's Days Payable compare to OPGN and AFIB?
Biolase's Days Payable of 59.90 can be compared against companies in the Medical Devices & Instruments industry. The industry median Days Payable is 68.07. Biolase's value of 59.90 is 12% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biolase's current Days Payable of 59.90 is 12% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Biolase and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biolase's current Days Payable is 59.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biolase stock overvalued right now?
Biolase (BIOLQ) has a current Days Payable of 59.90. The current Days Payable is 59.90 and 12% below the Medical Devices & Instruments industry median of 68.07. Biolase's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Biolase (BIOLQ), the current Days Payable is 59.90 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
16GF Score
Get the complete analysis for BIOLQ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOLQ has been successfully added to your 
